Head-to-Head
Full Comparison
Key attributes side by side. Advantage indicators reflect general clinical consensus; individual patient circumstances always apply.
| Attribute | Lipitor (atorvastatin) | Crestor (rosuvastatin) |
|---|---|---|
| Drug class | HMG-CoA reductase inhibitor (statin) | HMG-CoA reductase inhibitor (statin) |
| Primary use | Lower LDL cholesterol; reduce risk of heart attack, stroke, and cardiovascular events | Lower LDL cholesterol; reduce risk of heart attack, stroke, and cardiovascular events |
| Potency per mg |
High-intensity statin; LDL reductions of 43–57% at higher strengths
■ Both high-intensity capable |
Most potent statin per milligram; greater LDL lowering at equivalent strengths
▲ Higher potency per mg |
| Metabolism |
Extensively metabolized via CYP3A4 liver enzyme
More interaction potential |
Minimally metabolized; does not rely on CYP3A4
▲ Fewer CYP3A4 interactions |
| Drug interactions | More interactions due to CYP3A4 pathway — caution with certain antibiotics, antifungals, some calcium channel blockers, grapefruit juice |
Fewer interactions overall; still caution with some antacids and certain immunosuppressants
▲ Simpler interaction profile |
| Available strengths | 10 mg · 20 mg · 40 mg · 80 mg tablets | 5 mg · 10 mg · 20 mg · 40 mg tablets |
| Dosing frequency | Once daily (any time of day) | Once daily (any time of day) |
| Solubility | Lipophilic (fat-soluble); crosses blood-brain barrier more readily |
Relatively hydrophilic (water-soluble); more selective for the liver
▲ More liver-selective |
| Generic available |
Yes — generic atorvastatin widely available since 2012
▲ Longer generic history |
Yes — generic rosuvastatin available in US since ~2016
■ Also generic |
| Brand manufacturer | Pfizer (original brand) | AstraZeneca (original brand) |
| Approval year (US) | 1996 | 2003 |
| Cost (generic) | Inexpensive; often available through $4 generic programs | Inexpensive; widely available at generic pricing |
| Muscle side effects | Myalgia possible (statin class effect); generally well tolerated | Myalgia possible (statin class effect); generally well tolerated |
| Key landmark trial | TNT, CARDS, ASCOT-LLA | JUPITER, METEOR, ASTEROID |
| Best for | High-intensity LDL lowering; most prescribed in US; robust long-term safety data |
Patients on many medications (fewer CYP3A4 interactions); highest potency per mg needed
▲ Edge in polypharmacy patients |
What Sets Them Apart
Key Differences
Potency per milligram
Rosuvastatin is the most potent statin per milligram of any approved drug in its class. It achieves greater LDL reduction at a numerically lower strength than atorvastatin. For patients who need maximum LDL lowering, this difference can be clinically meaningful.
LipitorHigh-intensity at 40–80 mg
CrestorHigh-intensity at 20–40 mg
CYP3A4 Metabolism
Atorvastatin is a substrate of the CYP3A4 enzyme. Many common drugs — including certain antibiotics (erythromycin, clarithromycin), antifungals (itraconazole), and some HIV medications — inhibit CYP3A4 and can raise atorvastatin levels, increasing the risk of side effects. Rosuvastatin avoids this pathway entirely.
LipitorCYP3A4 substrate — more interactions
CrestorNot a CYP3A4 substrate
Polypharmacy patients
For patients who take many medications, rosuvastatin's simpler interaction profile often makes it easier to manage. Patients on complex regimens for HIV, transplant, or certain heart conditions may be better candidates for rosuvastatin, though a pharmacist or prescriber should always review the full medication list.
LipitorReview CYP3A4 interactions carefully
CrestorGenerally preferred in polypharmacy
Water vs. fat solubility
Atorvastatin is lipophilic, meaning it dissolves more readily in fat and can cross the blood-brain barrier. Rosuvastatin is more hydrophilic (water-soluble) and more selectively taken up by liver cells. Whether this difference affects tolerability in practice is an area of ongoing research.
LipitorLipophilic
CrestorHydrophilic — more liver-selective
Track record & data volume
Atorvastatin was approved in the US in 1996, giving it a longer track record and a larger body of real-world safety data. It became the world's best-selling drug of all time before its patent expired. Rosuvastatin was approved in 2003 and also has extensive clinical trial data, including the landmark JUPITER trial.
LipitorApproved 1996 — more long-term data
CrestorApproved 2003 — large trial evidence
Grapefruit interaction
Because atorvastatin is metabolized by CYP3A4, consuming large amounts of grapefruit or grapefruit juice can inhibit that enzyme and raise drug levels. Rosuvastatin does not interact with grapefruit in the same way, making it the simpler option for patients who regularly consume grapefruit products.
LipitorAvoid large amounts of grapefruit
CrestorNo grapefruit interaction
What They Share
Common Ground
Formulations
Available Strengths
Tablet strengths approved in the United States. Specific strength availability may vary by country and manufacturer. This is not dosing guidance — your prescriber determines the appropriate strength.
Lipitor / atorvastatin
10 mg
20 mg
40 mg
80 mg
Crestor / rosuvastatin
5 mg
10 mg
20 mg
40 mg
Frequently Asked Questions
Common Questions
-
Rosuvastatin (Crestor) is more potent per milligram than atorvastatin (Lipitor). Milligram for milligram, rosuvastatin lowers LDL cholesterol more than atorvastatin. However, both drugs are available in high-intensity strengths capable of reducing LDL by 50% or more. The best statin for a given patient depends on their individual cholesterol targets, tolerability, and other medications — a prescriber should make this determination.
-
Crestor (rosuvastatin) generally has fewer drug interactions than Lipitor (atorvastatin). Atorvastatin is metabolized by the CYP3A4 enzyme system, which is inhibited by many common drugs including certain antibiotics, antifungals, and calcium channel blockers. Rosuvastatin does not rely on CYP3A4 for metabolism, so it avoids many of these interactions. Patients taking multiple medications may find rosuvastatin simpler to manage from an interaction standpoint.
-
Yes. Generic atorvastatin (the active ingredient in Lipitor) has been available in the United States since 2012 and is widely available at low cost. Generic rosuvastatin (Crestor) became broadly available in the US starting around 2016. Both generics are inexpensive at most pharmacies, and either may be available through $4 generic programs.
-
Atorvastatin (Lipitor) and rosuvastatin (Crestor) are both HMG-CoA reductase inhibitors (statins) that lower LDL cholesterol and reduce cardiovascular risk. The key differences are: rosuvastatin is more potent per milligram; atorvastatin is metabolized via CYP3A4, which creates more drug-drug interaction potential; rosuvastatin is slightly more hydrophilic (water-soluble) than atorvastatin. Both are taken once daily and both have been shown to reduce the risk of heart attack, stroke, and cardiovascular death.
-
Switching between atorvastatin and rosuvastatin is common in clinical practice. Because rosuvastatin is more potent per milligram, the equivalent LDL-lowering effect is achieved at a lower number of milligrams. Your prescriber can determine the appropriate strength when switching. Never change your medication without speaking with your doctor or pharmacist first.
-
Muscle-related side effects (myalgia) are a class effect of all statins, including both atorvastatin and rosuvastatin. Most patients tolerate both drugs well. Severe muscle breakdown (rhabdomyolysis) is rare but serious with any statin. Some patients who experience muscle pain on one statin may tolerate another statin better. Report unexplained muscle pain or weakness to your prescriber promptly.
Related Comparisons